VBValentina G. Breusenko

Valentina G. Breusenko

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Valentina G. Breusenko has a total of 46 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Morpho-functional features of the endometrium in uterine leiomyoma before and after embolization of the uterine arteries

    by M.A. Kudimova, L.M. Mikhaleva, I.A. Krasnova, V.G. Breusenko, I.A. Esipova, S.A. Mikhalev, N.A. Gracheva

    The question of the degree of influence of uterine artery embolization (UAE) on fertility is open. It is important to evaluate the pathomorphological structure and functional activity of the endometrium, the disruption of which can lead to infertility. Objective. To study morpho-functional changes in the endometrium of patients with uterine fibroids before and after UAE. Material and methods. 116 patients were divided into 2 groups depending on the type of the leading fibroid node: 1st — 54 patients examined with uterine fibroid (UF) types 2, 2—5, 3, 2nd — 62 patients observed with UM types 4, 5, 6. The comparison group — 30 healthy women. Aspiration biopsy of the endometrium was performed in the middle stage of the secretory phase before and 6—12 months after UAE. The percentage and maturity of pinopodes, the expression level of estrogen (ER), progesterone (PR) receptors in the glands, endometrial stroma, inflammatory markers (CD56+, CD138+) were determined. Results. The negative impact of UF on the morpho-functional state of the endometrium was determined. Changes were more pronounced in patients of 1st group. Stroma indices before and after UAE corresponded to comparison group in most patients. After UAE, the number of mature pinopodes decreased in 1st group, but not in 2nd group. ER and PR expression levels in the glandular component decreased in all patients, being consistently higher in 1st group. An increase in proinflammatory markers was observed only in 1st group. Conclusion. UF and UAE can disturb morpho-functional state of the endometrium. The impact assessment should be made taking into account the topographic and anatomical location of the myomatous node.


  • Endometrial proliferative processes in postmenopausal patients and steroid transcriptome of peripheral blood mononuclear cells. Is there an association?

    by D.S. Gutorova, V.G. Breusenko, L.M. Kappusheva, G.N. Golukhov, E.V. Krasnoshchok, N.A. Kochina, A.V. Ovchinnikova, Yu.A. Golova, E.I. Baisova, E.N. Kaukhova

    Objective. To study the receptor profile of pathological endometrial tissue and peripheral blood mononuclear cells (PBMCs) in postmenopausal patients with endometrial proliferative processes (EPPs) and to determine the possible association between hormone-dependent and immune mechanisms of proliferation development. Patients and methods. The study included 85 postmenopausal patients with endometrial pathology: atypical endometrial hyperplasia (AEH) (n = 8), adenocarcinoma (AC) (n = 40), endometrial polyps (EP) (n = 37). The comparison group for the study of PBMCs were 10 healthy postmenopausal women. The expression levels of ERa, ERb, mER, PRA, PRB, mPR, PGRmC1 were evaluated in the endometrial tissue and PBMCs by real-time PCR. Results. The group of AEH showed high expression levels of ERb, PRA, PRB, mPR and low ERa in tissue compared to EP group; higher PRA, mPR, PGRmC1 in tissue were detected in AEH group compared to AC. In PBMCs, AEH group had higher ERa, mER, PRA compared to healthy women. Conclusion. The results of this study suggest that receptor transcriptome of EPP changes not only in pathological tissue, but also in immunocompetent cells, which, on the one hand, may contribute to the preservation of pathological tissue by suppressing the anti-tumor activity of cells, and, on the other hand, may potentially explain the ineffectiveness of hormone therapy. Key words: endometrial proliferative processes, endometrial hyperplasia, endometrial polyp, endometrial cancer, peripheral blood mononuclear cells, receptivity, pathogenesis, postmenopause

  • Anatomic and functional status of the uterus after transcervical myomectomy

    by V.G. Breusenko, I.A. Esipova, L.M. Kappusheva, G.N. Golukhov, Yu.A. Golova, B.I. Baisova, K.I. Stepanov, D.M. Lyafisheva, A.V. Ovchinnikova, D.S. Gutorova

    Objective. To improve the efficiency of transcervical myomectomy of submucosal myomatous nodules of different types on the basis of studying the character, terms of regenerative processes in the uterine wall and rehabilitation measures. Material and methods. 177 patients of reproductive age who underwent transcervical myomectomy were examined. The distribution of patients into groups was carried out depending on the type of the leading node: the 1st group consisted of 21 patients with type 0 nodes, the 2nd group included 93 patients with type I nodes, the 3rd group consisted of 63 patients with type II nodes. Results. Pregnancy can be considered in 12 months after myomectomy of type 0 fibroid, in 3 months after myomectomy of type I fibroid. Uterus recovery after myomectomy of type II fibroid should be evaluated by assessing myometrium using ultrasound. Hormonal therapy with estrogen-gestagen medication is considered obligatory if the diameter of removed type II fibroid exceeds 2.02.5cm and following two-stage myomectomy. Conclusion. Transcervical myomectomy is a safe technique for surgical treatment of submucous fibroids. Correct performance of the procedure (electrosurgical resection combined with «cold loop» technique and administration of uterotonics), estrogen-gestagen medication and post-surgical follow-up result in adequate uterus recovery.

  • Open Access

    Prognostic significance of the immunohistochemical status of the endometrium as markers of therapy for endometrial hyperplasia

    by Lyudmila M. Mikhaleva Mikhaleva, Laura M. Kappusheva, Georgiy N. Golukhov, Kristina V. Shcherbatyuk, Dina S. Gutorova, Anstasiya V. Ovchinnikova, Bella I. Baisova, Valentina G. Breusenko, Михалёва Людмила Михайловна, Голухов Георгий

    BACKGROUND: In patients of reproductive age with endometrial hyperplasia without atypia, hormonal treatment, and prognosis of response remain relevant issues. AIM: To increase the effectiveness of hormonal therapy for endometrial hyperplasia in patients of reproductive age with abnormal uterine bleeding, considering the receptivity, and proliferative activity of the endometrium. MATERIALS AND METHODS: A total of 179 patients of reproductive age with abnormal uterine bleeding and endometrial hyperplasia were examined. After the removal of the endometrial tissue, hormonal therapy was performed for 6 months: 101 patients received dydrogesterone 20 mg/day, and 78 patients received norethisterone acetate 10 mg/day. The expression levels of estrogen receptor- (Er), progesterone receptor (PR), and Ki67 in the endometrial tissue were determined by immunohistochemistry at baseline and 3 months after the treatment. The comparison group consisted of 18 women without gynecological pathology. Variation statistics methods were used to process the data, the differences between the indicators groups of patients were considered significant at p 0.05. RESULTS: Before treatment, the expression levels of ER, PR in both compartments, and Ki-67 in the glands were lower (p 0.05) in the endometrial hyperplasia group than in the control group. Remission was achieved in 77 (76.24%) (dydrogesterone) and 62 (79.49%) (norethisterone acetate) patients. Initially, the expression level of ER in the glands and stroma of endometrial hyperplasia was lower (p 0.05) than that in the comparison group; the resistant group had a lower (p 0.05) response to treatment. The expression of PR in the resistant group was lower (p 0.05) than that in the comparison group and remission group. The expression level of Ki67 in the response group was lower than that in the comparison group (p 0.05), and the expression in the stroma was lower than that in the resistant group (p 0.05). After treatment in both compartments, the expression levels of ER and PR were lower in the resistant group than in the comparison group and response group (p 0.05). A logistic regression equation was obtained with a set of predictors: ER (glands) + PR (glands and stroma) + Ki-67 (stroma) with a potential response to therapy of 93%. CONCLUSIONS: The specified predictive model is promising. The therapy was effective in 93% of cases.

  • Benign intrauterine diseases in post menopause. Organ-preserving methods of treatment

    by V.G. Breusenko, L.M. Kappusheva, G.N. Golukhov, Yu.A. Golova, I.A. Esipova, E.I. Baisova, K.I. Stepanov, A.V. Ovchinnikova, T.A. Plakhova, D.S. Gutorova

    Objective. To develop a differentiated approach to the treatment of patients with benign intrauterine diseases in the postmenopausal period on the basis of comparative evaluation of different organ-preserving methods of intrauterine surgery. Material and methods. 288 postmenopausal patients with benign intrauterine diseases were examined. Patients were divided into 4 groups depending on the used method of pathological focus removal from the uterine cavity: The 1st group consisted of 82 patients who underwent mechanical removal of the pathological focus; the 2nd group consisted of 58 patients who underwent electromechanical removal of the pathological focus; the 3rd group consisted of 46 patients who underwent local electrosurgical resection of the endometrium; the 4th group consisted of 102 patients who underwent total electrosurgical resection of the endometrium. Conclusion. All the methods of intrauterine surgery used by us can be differentially applied for the treatment of patients with benign intrauterine pathology depending on its nature and concomitant intrauterine and extragenital diseases, clinic equipment and surgeon’s experience. Electromechanical morcellation should be considered as the method of choice for removal of large endometrial polyps. In postmenopausal patients with benign intrauterine diseases, especially recurrent ones, and severe extragenital pathology, which is a contraindication to hysterectomy, total electrosurgical resection of endometrium may be the method of treatment of choice. Results. The efficiency of mechanical removal of pathological focus was 96.3%, electromechanical — 96.5%, local electrosurgical resection of endometrium — 97.4%, total electrosurgical resection of endometrium — 99.0%.

  • Hormonal therapy in patients of reproductive age with endometrial hyperplasia without atypia. Immunohistochemical predictors of efficacy

    by L.M. Kappusheva, L.M. Mikhaleva, V.G. Breusenko, G.N. Golukhov, K.Yu. Midiber, A.E. Biryukov, A.V. Ovchinnikova, D.S. Gutorova, K.V. Scherbatyuk

    ЦЕЛЬ ИССЛЕДОВАНИЯ Оценка иммуногистохимических параметров эндометрия у пациенток с гиперплазией эндометрия без атипии и аномальным маточным кровотечением (АМК) как предикторов эффективности гормональной терапии. МАТЕРИАЛ И МЕТОДЫ Обследованы 78 пациенток репродуктивного периода с АМК. Выполнены гистероскопия, раздельное диагностическое выскабливание слизистой оболочки матки. При гистологическом исследовании эндометрия выявлена гиперплазия эндометрия без атипии. Проведена терапия норэтистерона ацетатом в дозе 10 мг/сут в циклическом режиме в течение 6 мес. Через 3 мес после окончания лечения выполнена аспирационная биопсия эндометрия. По результатам гистологического исследования ретроспективно больные разделены на две группы: с эффектом от лечения (1-я группа) — 62 (79,49%) пациентки и без него (2-я группа) — 16 (20,51%), у которых была вновь диагностирована гиперплазия эндометрия. До лечения и после него проведено иммуногистохимическое исследование (ИГХИ) биоптатов эндометрия с определением экспрессии ERα, PR-A, PR-B, Ki-67. Контрольную группу составили 18 здоровых женщин. РЕЗУЛЬТАТЫ У пациенток с эффектом от терапии, по данным ИГХИ, выявлена исходно достоверно низкая экспрессия ERα в стромальном и железистом структурных компонентах эндометрия по сравнению с таковой у здоровых женщин. После лечения все показатели достигали нормы. У пациенток с вновь диагностированной гиперплазией эндометрия выявлены исходно низкие уровни экспрессии ERα, PR-A, PR-B в железистом и стромальном структурных компонентах эндометрия по сравнению с таковыми у здоровых женщин и пациенток 1-й группы (за исключением ERα в строме), после лечения эти изменения сохранялись. Экспрессия Ki-67 была исходно выше у пациенток 2-й группы по сравнению с этим показателем в 1-й группе. ЗАКЛЮЧЕНИЕ В ткани эндометрия до лечения целесообразно определять иммуногистохимические маркеры, которые могут быть перспективными предикторами эффективности гормональной терапии у пациенток репродуктивного возраста с гиперплазией эндометрия без атипии и аномальными маточными кровотечениями.


  • Modern aspects of endoscopic surgery in gynecology

    by G. M. Savelieva, V. G. Breusenko, L. M. Kappusheva, O. V. Aziev, Савельева Г. М., Бреусенко В. Г., Каппушева Л. М., Азиев О. В.

    133003 hysteroscopies (including3624 operative ones) and 8401 laparoscopic interventions were performed since 1996 to 2000. On the basis of rich experience the results of treating gynecologic pathology with the method of endoscopy were analyzed and the perspectives of its further development were determined.

  • Open Access

    Effichiency of contemporary methods of internal endometriosis (adenomyosis) treatment

    by L. M. Kappusheva, V. G. Breusenko, Каппушева Л. М., Бреусенко В. Г.

    The main treatment method of the internal endometriosis nowadays is still surgical method - hysterectomy by laparoscopic or laparotomic way. The histeroscopic endometrial resection (ablation) is an alternative with regard of hysterectomy in female patients with surface adenomyosis forms in absence of pain syndrome. According to available information on our investigation, the endometrial resection (ablation) is very effective in 72% of female patients with adenomyosis combined with recidive endometrial hyperplasia.

  • Steroid Receptors of Endometrial Tissue and Ovaries in Postmenopausal Patients with Endometrial Disorders

    by G. M. Saveljeva, P. V. Sergeev, V. G. Breusenko, L. M. Kappusheva, E. N. Mineeva